Cargando…

Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1

Due to drug resistance, the clinical response to cisplatin (CDDP) from patients with liver cancer is unsatisfactory. The alleviation or overcoming of CDDP resistance is an urgent problem to be solved in clinics. Tumor cells rapidly change signal pathways to mediate drug resistance under drug exposur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Li, Mengzhu, Xu, Duo, Jiang, Zebo, Jiang, Hailong, Xiao, Yitai, Mei, Chaoming, Yang, Meilin, Chen, Congmin, Zhou, Bin, He, Bailiang, Shan, Hong, Pang, Pengfei, Li, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197891/ https://www.ncbi.nlm.nih.gov/pubmed/37215991 http://dx.doi.org/10.7150/ijbs.79163

Ejemplares similares

Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
por: Brandt, B, et al.
Publicado: (2010)

ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis
por: Sun, Jia, et al.
Publicado: (2023)

Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis
por: Pant, Ila, et al.
Publicado: (2016)

Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
por: Echevarría-Vargas, Ileabett M., et al.
Publicado: (2014)

Correction: Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
Publicado: (2014)

BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways
por: Jiao, Chen Yu, et al.
Publicado: (2021)

FK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy
por: Guo, Enshuang, et al.
Publicado: (2017)

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation
por: Anfinogenova, Nina D., et al.
Publicado: (2020)

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
por: Chen, Jing, et al.
Publicado: (2021)

RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway
por: Zhang, Deyu, et al.
Publicado: (2021)

Overexpressed DNA Polymerase Iota Regulated by JNK/c-Jun Contributes to Hypermutagenesis in Bladder Cancer
por: Yuan, Fang, et al.
Publicado: (2013)

Nanoparticle-Mediated Delivery of Satraplatin to Overcome Cisplatin Drug Resistance
por: Jiang, Xiaohan, et al.
Publicado: (2023)

Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38
por: Kirsch, Klára, et al.
Publicado: (2020)

Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition
por: Clarke, Melanie, et al.
Publicado: (2012)

Nerve Injury-Induced c-Jun Activation in Schwann Cells Is JNK Independent
por: Lindwall Blom, Charlotta, et al.
Publicado: (2014)

MALT1 promotes melanoma progression through JNK/c-Jun signaling
por: Wang, Y, et al.
Publicado: (2017)

Activation of c-Jun by human cytomegalovirus UL42 through JNK activation
por: Koshizuka, Tetsuo, et al.
Publicado: (2020)

UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
por: Zhou, Sitong, et al.
Publicado: (2021)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

ATF3 acts as a rheostat to control JNK signalling during intestinal regeneration
por: Zhou, Jun, et al.
Publicado: (2017)

TGF-β3 regulates adhesion formation through the JNK/c-Jun pathway during flexor tendon healing
por: Jiang, Ke, et al.
Publicado: (2021)

TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway
por: Wang, Shu-Yang, et al.
Publicado: (2015)

Regulation of c-Jun NH(2)-terminal Kinase ( Jnk) Gene Expression during T Cell Activation
por: Weiss, Linda, et al.
Publicado: (2000)

Molecular docking of C-Jun-N-Terminal Kinase (Jnk) with amino-pyrimidine derivatives
por: Meenakumari, Krishnamoorthy, et al.
Publicado: (2020)

Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes
por: Yung, Justin Hou Ming, et al.
Publicado: (2020)

c-Jun NH(2)-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8(+) T Cell Activation
por: Conze, Dietrich, et al.
Publicado: (2002)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells
por: Han, Li, et al.
Publicado: (2014)

The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo
por: An, J J, et al.
Publicado: (2013)

Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c-JUN signaling pathway
por: Wang, Gengyin, et al.
Publicado: (2022)

Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury
por: Xu, Duo, et al.
Publicado: (2023)

NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells
por: Du, Aolin, et al.
Publicado: (2018)

Citrus Naringenin Increases Neuron Survival in Optic Nerve Crush Injury Model by Inhibiting JNK-JUN Pathway
por: Chen, Jie, et al.
Publicado: (2021)

Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation
por: Li, Qing V., et al.
Publicado: (2019)

Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network
por: Ahmed, Shafiq Uddin, et al.
Publicado: (2009)

Rhein induces liver cancer cells apoptosis via activating ROS-dependent JNK/Jun/caspase-3 signaling pathway
por: Wang, Aili, et al.
Publicado: (2020)

Activation of c-Jun N-Terminal Kinase (JNK) during Mitosis in Retinal Progenitor Cells
por: Ribas, Vinicius Toledo, et al.
Publicado: (2012)

C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media
por: Yao, William, et al.
Publicado: (2014)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer
por: Cai, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aalv17v3eo48ed94tuj33hbip2